1) Jie Li, Biyao Zou, Yee Hui Yeo, Yuemin Feng, Xiaoyu Xie, Dong Hyun Lee, Hideki Fujii, Yuankai Wu, Leslie Y. Kam, Fanpu Ji, Xiaohe Li, Nicholas Chien, Mike Wei, Eiichi Ogawa, Changqing Zhao, Xia Wu, Christopher D. Stave, Linda Henry, Scott Barnett, Hirokazu Takahashi, Norihiro Furusyo, Yuichiro Eguchi, Yao-Chun Hsu, Teng-Yu Lee, Wanhua Ren, Chengyong Qin, Dae Won Jun, Hidenori Toyoda, Vincent Wai-Sun Wong, Ramsey Cheung, Qiang Zhu, Mindie H. Nguyen. Prevalence, Incidence, and Outcome of Non-alcoholic Fatty Liver Disease in Asia, 1999-2019: A Systematic Review and Meta-analysis. The Lancet Gastroenterology & Hepatology. 2019 May;4(5):389-398. doi: 10.1016/S2468-1253(19)30039-1. (IF=38.6)（中科院分区：1区）（ESI高被引论文）
2) Fajuan Rui, Wenjing Ni, Junping Shi, Qing Xie*, Jie Li*. Superior Diagnostic Efficacy of AGILE 3+ Score for Diagnosing Advanced Fibrosis in Chronic Hepatitis B patients with Concurrent Metabolic Dysfunction-Associated Steatotic Liver Disease. Journal of Hepatology 2024 Dec;81(6):e295-e297. (IF=33.0)（中科院分区：1区）
3) Yingrui Wang#, Qianru Zhu#, Rui Sun#, Xiao Yi#, Lingling Huang, Yifan Hu, Weigang Ge, Huanhuan Gao, Xinfu Ye, Yu Song, Li Shao, Yantao Li, Jie Li*, Tiannan Guo*, Junping Shi* Longitudinal proteomic investigation of COVID-19 vaccination. Protein & Cell. 2023 Sep 14;14(9):668-682. (IF=12.8)（中科院分区：1区）（共同通讯作者）
4) Jie Li, Liang Xu, Fajuan Rui, Sally Tran, Pei-Chien Tsai, Youwen Tan, Hidenori Toyoda, Qing-Lei Zeng, Huy Trinh, Yao-Chun Hsu, Tsunamasa Watanabe, Hiroshi Abe, Hiroyuki Motoyama Yoko Yoshimaru, Takanori Suzuki, Taeang Arai, Masanori Atsukawa, Phillip Vutien, Sebastián Marciano, Xue Bai, Wenjing Ni, Nan Geng, Cheng-Hao Tseng, Jiacheng Liu, Yuqiang Mi, Jing Liu, Yun Ye, Li Zhu, Chen Ru-yue, Chuanwu Zhu, Mayumi Maeda, Joanne Kimiko Liu, Linda Henry, Ming-Lun Yeh, Chung-Feng Huang, Jee-Fu Huang, Chia-Yen Dai, Adrian Gadano, Ramsey Cheung, Wan-Long Chuang, Masaru Enomoto, Yasuhito Tanaka, Shinichi Aishima, Ming-Lung Yu, Chao Wu, Junping Shi*, Mindie H. Nguyen*, Type 2 Diabetes mellitus as an independent predictor of significant fibrosis in treatment-naïve chronic hepatitis B patients with concurrent hepatic steatosis Hepatology. 2025. (IF=15.8)（中科院分区：1区）
5) Jie Li, Fajuan Rui, Mindie H. Nguyen*, Reply:Type 2 Diabetes mellitus as an independent predictor of significant fibrosis in treatment-naive chronic hepatitis B patients with concurrent hepatic steatosis Hepatology. 2025. (IF=15.8)（中科院分区：1区）
6) Xiaolong Qi*, Jie Li*, Cyrielle Caussy, Gao-Jun Teng, Rohit Loomba. Epidemiology, Screening, and Co-management of Type 2 Diabetes Mellitus and Metabolic-dysfunction associated Steatotic Liver Disease. Hepatology. 2024. (IF=15.8)（中科院分区：1区）（共同第一作者）（ESI高被引论文）
7) Qianwen Zhao#, Hong Liu#, Zhen Yang#, Xingxing Han, Aoqi Kang, Hao Li, Wenjing Ren, Qianqian Chen, Yue Huan, Yong Xu, Jie Li*, Ming Kong*, Zilong Li*. Pre-B-Cell leukemia transcription factor 1 contributes to liver fibrosis by enabling IL-7 signaling in hepatic stellate cells. Hepatology. 2025. (IF=15.8)（中科院分区：1区）（共同通讯作者）
8) Fajuan Rui#, Yee Hui Yeo#, Liang Xu#, Qi Zheng, Xiaoming Xu, Wenjing Ni, Youwen Tan, Qing-lei Zeng, Zebao He, Xiaorong Tian, Qi Xue, Yuanwang Qiu, Chuanwu Zhu, Weimao Ding, Jian Wang, Rui Huang, Yayun Xu, Yunliang Chen, Junqing Fan, Zhiwen Fan, Xiaolong Qi, Daniel Q. Huang, Qing Xie*, Junping Shi*, Chao Wu‡, Jie Li*. Development of a machine learning-based model to predict hepatic inflammation in chronic hepatitis B patients with concurrent hepatic steatosis: a cohort study. eClinicalMedicine. 2024 Jan 16;68:102419. (IF=10)（中科院分区：1区）
9) Jiawen Zhou, Xinyue Sun, Xuelian Chen, Huimin Liu, Xiulian Miao, Yan Guo, Zhiwen Fa, Jie Li*, Yong Xua*, Zilong Li*. Phosphatidic acid-enabled MKL1 contributes to liver regeneration: Translational implication in liver failure. Acta Pharmaceutica Sinica B. 2024 Jan;14(1):256-272 (IF=14.6)（中科院分区：1区）（共同通讯作者）
10)Jing Shi#, Zhenzhen Feng, Qian Song, Aijia Wen, Tianyu Liu, Liqiao Xu, Zonghang Ye, Simin Xu, Fei Gao, Liuxiang Xiao, Jiapeng Zhu, Kalyan Das, Guoping Zhao, Jie Li # Yu Feng#, and Wei Lin#. Structural insights into transcription regulation of the global OmpR/PhoB family regulator PhoP from Mycobacterium tuberculosis. Nature communications 2025 Feb 13;16(1):1573 (IF=15.7)（中科院分区：1区）（共同通讯作者）
11)Multi-modal AI for Opportunistic Screening, Staging and Progression Risk Stratification of Steatotic Liver Disease Nature communications 2025 (IF=15.7)（中科院分区：1区）（共同通讯作者）
12)Xiangyu Wu#, Wenjing Ni#, Qianqian Chen, Junping Shi*, Jie Li*. MAFLD-related hepatocellular carcinoma in China: an increasing problem. Clinical and Molecular Hepatology 2024 Oct;30(4):965-969 . (IF=16.9)（中科院分区：1区）
13)Yixuan Zhu*, Yee Hui Yeo*, Xiaoyan Ma, Wenjing Ni Junping Shi#, Jie Li #. Metabolic-associated fatty liver disease is less effective in predicting mortality than non-alcoholic fatty liver disease and metabolic dysfunction-associated steatotic liver disease. Clinical and Molecular Hepatology 2024 Oct;30(4):974-977 (IF=16.9)（中科院分区：1区）
14)Huan Zhang#, Xiangyu Wu# , Wenjing Ni#, Jiali Wu, Sisi Zhou, Leyao Jia, Mingyang Jin, Sitian Zhao, Zhenyang Jiang, Chao Wu，Yuxiang Sun，Junping Shi*, Jie Li* Application of machine learning and deep learning in Metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis Journal of Advanced Research 2025 (IF=13)（中科院分区：1区）
15)Yu Song#,Wenjing Ni#, Minghua Zheng#, Huiping Sheng#, Jing Wang#, Shilong Xie, YongFeng Yang, Xiaoling Chi, Jinjun Chen, Fangping He, Xiaotang Fan, Yuqiang Mi, Jing Zhang, Bingyuan Wang, Lang Bai, Wen Xie, Bihui Zhong, Yee Hui Yeo, Fajuan Rui, Shufei Zang*, Jie Li*, Junping Shi*, and the Chinese NAFLD Clinical Research Network (CNAFLD CRN).Vitamin E (300 mg) in the treatment of MASH: A multi-center, randomized, double-blind, placebo-controled study. Cell Reports Medicine, 2025 Feb 18; 6(2): 101939(IF=10.6)（中科院分区：1区）（ESI高被引论文）
16)Yee Hui Yeo*, Yixuan Zhu*, Juan Pablo Arab, Wenjing Ni, Xiaoming Xu, Junping Shi#, Jie Li#. Alcohol Intake Thresholds in Individuals with Steatotic Liver Disease. JAMA Network Open 2023 Dec 1;6(12):e2347548. doi: 10.1001/jamanetworkopen.2023.47548. (IF=9.7)（中科院分区：1区）
17)Chuan Liu#, Jie Shen#, Jie Li#, Zhihui Li#, Ming-Hua Zheng#, Hua Bian#, Xiqiao Zhou#, Wenjing Ni#, Zhongji Meng#, Jiaojian Lv#, Yijun Tang, Xuan Liang, Min Li, Taolong Zhou, Heng Wan, Yuping Chen, Yuxia Qi, Yuli Ge, Yan Wang, Wen-Yue Liu, Mingxing Huang, Shanghao Liu, Xiaomei Wang, Mingfeng Xia, Xuefeng Li, Yuehua Wang, Xinjie Li, Xiaoxiong Hu, Yan Wu, Huimin Ying, Jing He, Fengmei Wang, Wei Yan, Huili Wu, Qingge Zhang, Weimin Jiang, Yan Huang, Yudong Zhang, Hongliang He, Xiaofeng Wu, Yuwei Zhang, Ling Li, Terry Cheuk-Fung Yip, Gao-Jun Teng*, Xiaolong Qi*. DiabetesLiver score: a non-invasive algorithm for advanced liver fibrosis and liver-related outcomes in type 2 diabetes mellitus population Med 2025 Aug 8;6(8):100700. (IF=11.8)（中科院分区：1区）（共同第一作者）
18)Jie Li, Ramsey C. Cheung, Nonalcoholic Fatty Liver Disease in Children: where are we? Clinical Gastroenterology and Hepatology. 2022 Oct;20(10):2210-2215.doi: 10.1016/j.cgh.2022.02.008. (IF=12)（中科院分区：1区）
19)Fajuan Rui#, Liang Xu#, Yee Hui Yeo#, Yayun Xu#, Wenjing Ni#, Qi Zheng, Xiaorong Tian, Qing-lei Zeng, Zebao He, Yuanwang Qiu, Chuanwu Zhu,Weimao Ding, Jian Wang, Rui Huang, Qi Xue, Xueqi Wang, Yunliang Chen,Junqing Fan, Zhiwen Fan, Eiichi Ogawa , Min-Sun Kwak, Xiaolong Qi*, Junping Shi*, Vincent Wai-Sun Wong‡, Chao Wu‡, Jie Li*. Machine learning-based models for identifying advanced fibrosis and cirrhosis in chronic hepatitis B patients with concurrent hepatic steatosis. Clinical Gastroenterology and Hepatology. 2024 Jun 19:S1542-3565(24)00553-6 (IF=12)（中科院分区：1区）
20)Xiaoming Xu, Mindie H Nguyen, Jie Li. Chronic Hepatitis B and Steatotic Liver Disease: a Blessing in Disguise? Clinical Gastroenterology and Hepatology. 2023 Dec 8:S1542-3565(23) 01004-2 (IF=12)（中科院分区：1区）
21)Zebaohe, Jie Li, Comment on Cai et al. Obesity and COVID-19 severity in a designated hospital in Shenzhen, China. Diabetes Care. 2020; 43:1392-1398 (Letter).Diabetes Care. 2020;43:e160–e161.DOI:10.2337/dc20-1195. (IF=16.6)（中科院分区：1区）（通讯作者）
22)Jie Li, Ramsey C. Cheung, Mindie H. Nguyen, Letter to the Editor: Chronic Hepatitis B and Nonalcoholic Steatohepatitis: Is Fat All Bad? Hepatology. 2020;71:768. doi: 10.1002/hep.30983.(IF=15.8)（中科院分区：1区）
23)Jie Li, Mindie H. Nguyen, Screening for fatty liver disease and fibrosis in the elderly population: A call for action. Hepatology. 2023 Feb 1;77(2): E28-E29. doi: 10.1002/hep.32727. (IF=15.8)（中科院分区：1区）
24)Qianqian Chen#, Ming-Hua Zheng#, Li Zhu#, Wenjing Ni#, Yali Xiong, Xinyu Hu, Fajuan Rui, Rahma Issa, Yixuan Zhu, Leyao Jia,Scott Barnett, Shengxia Yin, Chuanwu Zhu, Chao Wu, Mindie H. Nguyen*, Jie Li*. Superior Diagnostic Efficacy of N-terminal Propeptide of Type III Collagen and Golgi Protein 73 for Detection of Fibrosis in Chronic Hepatitis B Patients. MedComm 2025 Jun 11;6(6):e70236( IF=10.7)（中科院分区：1区）